Medtronic PLC
$ 85.92
-0.08%
06 Aug - close price
- Market Cap 109,303,054,000 USD
- Current Price $ 85.92
- High / Low $ 87.30 / 85.67
- Stock P/E 23.03
- Book Value 38.64
- EPS 3.73
- Next Earning Report 2026-09-01
- Dividend Per Share $2.84
- Dividend Yield 3.3 %
- Next Dividend Date -
- ROA 0.05 %
- ROE 0.10 %
- 52 Week High 103.76
- 52 Week Low 72.65
About
Medtronic plc is an American-Irish registered medical device company that primarily operates in the United States. Medtronic has an operational and executive headquarters in Fridley, Minnesota in the US.
Analyst Target Price
$98.44
Quarterly Earnings
| Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 | Jan 2024 | Oct 2023 | Jul 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-06-03 | 2026-02-17 | 2025-11-18 | 2025-08-19 | 2025-05-21 | 2025-02-18 | 2024-11-19 | 2024-08-20 | 2024-05-23 | 2024-02-20 | 2023-11-21 | 2023-08-22 |
| Reported EPS | 1.55 | 1.36 | 1.36 | 1.26 | 1.62 | 1.39 | 1.26 | 1.23 | 1.46 | 1.3 | 1.25 | 1.2 |
| Estimated EPS | 1.54 | 1.34 | 1.31 | 1.23 | 1.58 | 1.36 | 1.25 | 1.2 | 1.45 | 1.26 | 1.18 | 1.11 |
| Surprise | 0.01 | 0.02 | 0.05 | 0.03 | 0.04 | 0.03 | 0.01 | 0.03 | 0.01 | 0.04 | 0.07 | 0.09 |
| Surprise Percentage | 0.6494% | 1.4925% | 3.8168% | 2.439% | 2.5316% | 2.2059% | 0.8% | 2.5% | 0.6897% | 3.1746% | 5.9322% | 8.1081% |
Next Quarterly Earnings
| Jul 2026 | |
|---|---|
| Reported Date | 2026-09-01 |
| Fiscal Date Ending | 2026-07-31 |
| Estimated EPS | 1.38 |
| Currency | USD |
Previous Dividend Records
| Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2026-07-17 | 2026-04-17 | 2026-01-16 | 2025-10-17 | 2025-07-11 | 2025-04-11 | 2025-01-10 | 2024-10-11 | 2024-07-12 | 2024-04-12 |
| Amount | $0.72 | $0.71 | $0.71 | $0.71 | $0.71 | $0.7 | $0.7 | $0.7 | $0.7 | $0.69 |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: MDT
2026-08-07 11:08:25
Palouse Capital Management Inc. significantly increased its stake in Medtronic PLC (NYSE:MDT) during the second quarter, acquiring an additional 29,275 shares to bring its total holdings to 57,027 shares valued at approximately $4.46 million. This move comes as Medtronic exceeded analyst expectations with its recent quarterly earnings, reporting $9.81 billion in revenue and adjusted EPS of $1.55, and raised its quarterly dividend to $0.72 per share. Despite a "Moderate Buy" consensus from analysts, the company faces potential litigation risks following an $88 million hernia-mesh verdict.
2026-08-07 09:50:21
This article features Intuitive Surgical CEO Dave Rosa discussing the future of robotic surgery. It highlights the company's role in advancing medical technology and briefly mentions other medical device news and political topics in the healthcare sector.
2026-08-07 08:10:28
Cerus Corp (CERS) has an earnings forecast score of 8.67, ranking 17th in its industry, with an average analyst price target of $5.00, suggesting a 113.09% upside. Based on 3 analysts, the stock is rated as a "Buy." The company's expected revenue for the next quarter is $61.60 million, and its EPS for the previous and next quarters is estimated at -$0.01.
2026-08-07 07:51:40
180 Wealth Advisors LLC significantly reduced its stake in Medtronic PLC (NYSE:MDT) by 75% in the second quarter, selling 29,822 shares and retaining 9,951 shares valued at $778,000. Despite this reduction, Medtronic reported strong quarterly results with revenue of $9.81 billion and adjusted EPS of $1.55, exceeding analyst expectations, and increased its quarterly dividend. The company maintains a "Moderate Buy" consensus rating from analysts, though it faces litigation risk from an $88 million hernia-mesh lawsuit.
2026-08-07 07:44:40
Balefire LLC significantly reduced its stake in Medtronic PLC (NYSE:MDT) by 67.1% in the second quarter, selling 25,744 shares but still retaining 12,614 shares valued at $987,000. Despite this institutional sell-off and recent price target reductions by analysts, Medtronic holds a "Moderate Buy" consensus rating. The company reported strong quarterly earnings and raised its dividend but faces litigation risks from an $88 million jury award in a hernia-mesh case.
2026-08-06 17:40:47
AngioDynamics (ANGO) shares have significantly outperformed the market, gaining 33.5% in three months, driven by its shift towards higher-margin Med Tech platforms like NanoKnife and Auryon. While Med Tech growth and product differentiation support the company's momentum, concerns about valuation, tariff impact on earnings conversion, and a Zacks Rank #4 (Sell) signal suggest caution for investors. The article concludes that further upside requires sustained double-digit growth and clearer evidence of operating gains translating into stronger earnings.
